These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells. Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608 [TBL] [Abstract][Full Text] [Related]
3. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma. Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156 [TBL] [Abstract][Full Text] [Related]
4. In Vitro Gene Delivery with Large Porous Silicon Nanoparticles Fabricated Using Cost-Effective, Metal-Assisted Chemical Etching. Wareing N; Szymanski K; Akkaraju GR; Loni A; Canham LT; Gonzalez-Rodriguez R; Coffer JL Small; 2017 Jan; 13(3):. PubMed ID: 28084695 [TBL] [Abstract][Full Text] [Related]
5. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma. Tong WY; Alnakhli M; Bhardwaj R; Apostolou S; Sinha S; Fraser C; Kuchel T; Kuss B; Voelcker NH J Nanobiotechnology; 2018 Apr; 16(1):38. PubMed ID: 29653579 [TBL] [Abstract][Full Text] [Related]
6. pH and redox-operated nanovalve for size-selective cargo delivery on hollow mesoporous silica spheres. Zhu X; Wang CQ J Colloid Interface Sci; 2016 Oct; 480():39-48. PubMed ID: 27399617 [TBL] [Abstract][Full Text] [Related]
7. Unveiling the formation pathway of single crystalline porous silicon nanowires. Zhong X; Qu Y; Lin YC; Liao L; Duan X ACS Appl Mater Interfaces; 2011 Feb; 3(2):261-70. PubMed ID: 21244020 [TBL] [Abstract][Full Text] [Related]
8. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency. Li J; Zhang W; Gao Y; Tong H; Chen Z; Shi J; Santos HA; Xia B J Mater Chem B; 2020 Jan; 8(3):546-557. PubMed ID: 31854435 [TBL] [Abstract][Full Text] [Related]
9. Tailoring the biodegradability of porous silicon nanoparticles. Hon NK; Shaposhnik Z; Diebold ED; Tamanoi F; Jalali B J Biomed Mater Res A; 2012 Dec; 100(12):3416-21. PubMed ID: 22767395 [TBL] [Abstract][Full Text] [Related]
10. Cyclodextrin-Modified Porous Silicon Nanoparticles for Efficient Sustained Drug Delivery and Proliferation Inhibition of Breast Cancer Cells. Correia A; Shahbazi MA; Mäkilä E; Almeida S; Salonen J; Hirvonen J; Santos HA ACS Appl Mater Interfaces; 2015 Oct; 7(41):23197-204. PubMed ID: 26440739 [TBL] [Abstract][Full Text] [Related]
11. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer. Xia B; Wang B; Shi J; Zhang Y; Zhang Q; Chen Z; Li J Acta Biomater; 2017 Mar; 51():197-208. PubMed ID: 28069501 [TBL] [Abstract][Full Text] [Related]
12. Polyelectrolyte complex templated synthesis of monodisperse, sub-100 nm porous silica nanoparticles for cancer targeted and stimuli-responsive drug delivery. Newham G; Mathew RK; Wurdak H; Evans SD; Ong ZY J Colloid Interface Sci; 2021 Feb; 584():669-683. PubMed ID: 33223243 [TBL] [Abstract][Full Text] [Related]